Moreover, among the six M42 module members that were ranked top 20, three (APOE, FLT1, PTN), unlike MDK, NTN1, and APP, did not show high magnitude fold changes when comparing AD patients with healthy controls (ranging from 1.11 to 1.27 in proteomic data). This evidence concerns the gene NTN1 and Alzheimer disease.